Aberrant mitochondrial morphology and function associated with impaired mitophagy and DNM1L-MAPK/ERK signaling are found in aged mutant Parkinsonian LRRK2^R1441G mice

References

• Schapira AH. Mitochondria in the aetiology and pathogenesis of Parkinson’s disease. Lancet Neurol. 2008;7(1):97–109.
   PubMed Web of Science ®Google Scholar
• Abou-Sleiman PM, Muqit MM, Wood NW. Expanding insights of mitochondrial dysfunction in Parkinson’s disease. Nat Rev Neurosci. 2006;7(3):207–219.
   PubMed Web of Science ®Google Scholar
• Bolam JP, Pissadaki EK. Living on the edge with too many mouths to feed: why dopamine neurons die. Mov Disord. 2012;27(12):1478–1483.
   PubMed Web of Science ®Google Scholar
• Sprenger HG, The LT. Good and the bad of mitochondrial breakups. Trends Cell Biol. 2019;29(11):888–900.
   PubMed Web of Science ®Google Scholar
• Harper JW, Ordureau A, Heo JM. Building and decoding ubiquitin chains for mitophagy. Nat Rev Mol Cell Biol. 2018;19(2):93–108.
   PubMed Web of Science ®Google Scholar
• Ryan BJ, Hoek S, Fon EA, et al. Mitochondrial dysfunction and mitophagy in Parkinson’s: from familial to sporadic disease. Trends Biochem Sci. 2015;40(4):200–210.
   PubMed Web of Science ®Google Scholar
• Youle RJ, van der Bliek AM. Mitochondrial fission, fusion, and stress. Science. 2012;337(6098):1062–1065.
   PubMed Web of Science ®Google Scholar
• Twig G, Hyde B, Shirihai OS. Mitochondrial fusion, fission and autophagy as a quality control axis: the bioenergetic view. Biochim Biophys Acta. 2008;1777(9):1092–1097.
   PubMed Web of Science ®Google Scholar
• Breitzig MT, Alleyn MD, Lockey RF, et al. A mitochondrial delicacy: dynamin-related protein 1 and mitochondrial dynamics. Am J Physiol Cell Physiol. 2018;315(1):C80–C90.
   PubMed Web of Science ®Google Scholar
• Lou G, Palikaras K, Lautrup S, et al. Mitophagy and neuroprotection. Trends Mol Med. 2020;26(1):8–20.
   PubMed Web of Science ®Google Scholar
• Nalls MA, Pankratz N, Lill CM, et al. Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson’s disease. Nat Genet. 2014;46(9):989–993.
   PubMed Web of Science ®Google Scholar
• Dächsel JC, Farrer MJ. LRRK2 and Parkinson disease. Arch Neurol. 2010;67(5):542–547.
   PubMedGoogle Scholar
• Mata IF, Wedemeyer WJ, Farrer MJ, et al. LRRK2 in Parkinson’s disease: protein domains and functional insights. Trends Neurosci. 2006;29(5):286–293.
   PubMed Web of Science ®Google Scholar
• Taylor JP, Mata IF, Farrer MJ. LRRK2: a common pathway for parkinsonism, pathogenesis and prevention? Trends Mol Med. 2006;12(2):76–82.
   PubMed Web of Science ®Google Scholar
• Haugarvoll K, Rademakers R, Kachergus JM, et al. Lrrk2 R1441C parkinsonism is clinically similar to sporadic Parkinson disease. Neurology. 2008;70(16 Pt 2):1456–1460.
   PubMed Web of Science ®Google Scholar
• Volta M, Melrose H. LRRK2 mouse models: dissecting the behavior, striatal neurochemistry and neurophysiology of PD pathogenesis. Biochem Soc Trans. 2017;45(1):113–122.
   PubMedGoogle Scholar
• Xiong Y, Dawson TM, Dawson VL. Models of LRRK2-associated Parkinson’s disease. Adv Neurobiol. 2017;14:163–191.
   PubMedGoogle Scholar
• Yue Z, Lachenmayer ML. Genetic LRRK2 models of Parkinson’s disease: dissecting the pathogenic pathway and exploring clinical applications. Mov Disord. 2011;26(8):1386–1397.
   PubMed Web of Science ®Google Scholar
• Liu HF, Lu S, Ho PWL, et al. LRRK2 R1441G mice are more liable to dopamine depletion and locomotor inactivity. Ann Clin Transl Neurol. 2014;1(3):199–208.
   PubMed Web of Science ®Google Scholar
• Liu HF, Ho PWL, Leung GC, et al. Combined LRRK2 mutation, aging and chronic low dose oral rotenone as a model of Parkinson’s disease. Sci Rep. 2017;7:40887.
   PubMed Web of Science ®Google Scholar
• Ho PWL, Leung GC, Liu HF, et al. Age-dependent accumulation of oligomeric a-synuclein from impaired degradation in mutant LRRK2 knockin mouse model of Parkinson disease: role for therapeutic activation of chaperone-mediated autophagy (CMA). Autophagy. 2020;16(2):347–370.
   PubMed Web of Science ®Google Scholar
• Hsieh CH, Shaltouki A, Gonzalez AE, et al. Functional impairment in miro degradation and mitophagy is a shared feature in familial and sporadic Parkinson’s disease. Cell Stem Cell. 2016;19(6):709–724.
   PubMed Web of Science ®Google Scholar
• Cookson MR. Cellular functions of LRRK2 implicate vesicular trafficking pathways in Parkinson’s disease. Biochem Soc Trans. 2016;44(6):1603–1610.
   PubMedGoogle Scholar
• Geisler S, Holmström KM, Skujat D, et al. PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1. Nat Cell Biol. 2010;12(2):119–131.
   PubMed Web of Science ®Google Scholar
• Chan NC, Salazar AM, Pham AH, et al. Broad activation of the ubiquitin proteasome system by Parkin is critical for mitophagy. Hum Mol Genet. 2011;20:1726–1737.
   PubMed Web of Science ®Google Scholar
• Twig G, Shirihai OS. The interplay between mitochondrial dynamics and mitophagy. Antioxid Redox Signal. 2011;14(10):1939–1951.
   PubMed Web of Science ®Google Scholar
• Kim I, Rodriguez‐Enriquez S, Lemasters JJ. Selective degradation of mitochondria by mitophagy. Arch Biochem Biophys. 2007;462:245–253.
   PubMed Web of Science ®Google Scholar
• Carreira RS, Lee Y, Ghochani M, et al. Cyclophilin D is required for mitochondrial removal by autophagy in cardiac cells. Autophagy. 2010;6:462–472.
   PubMed Web of Science ®Google Scholar
• Mauro‐Lizcano M, Esteban‐Martinez L, Seco E, et al. New method to assess mitophagy flux by flow cytometry. Autophagy. 2015;11:833–843.
   PubMed Web of Science ®Google Scholar
• Ito G, Katsemonova K, Tonelli F, et al. Phos-tag analysis of Rab10 phosphorylation by LRRK2: a powerful assay for assessing kinase function and inhibitors. Biochem J. 2016;473(17):2671–2685.
   PubMedGoogle Scholar
• Doyle A, McGarry MP, Lee NA, et al. The construction of transgenic and gene knockout/knockin mouse models of human disease. Transgenic Res. 2012;21(2):327–349.
   PubMed Web of Science ®Google Scholar
• Pang SY, Ho PWL, Liu HF, et al. The interplay of aging, genetics and environmental factors in the pathogenesis of Parkinson’s disease. Transl Neurodegener. 2019;8:23.
   PubMed Web of Science ®Google Scholar
• Tolosa E, Vila M, Klein C, et al. LRRK2 in Parkinson disease: challenges of clinical trials. Nat Rev Neurol. 2020;16(2):97–107.
   PubMed Web of Science ®Google Scholar
• Chu CT. Mechanisms of selective autophagy and mitophagy: implications for neurodegenerative diseases. Neurobiol Dis. 2019;122:23–34.
   PubMed Web of Science ®Google Scholar
• Sarraf SA, Raman M, Guarani-Pereira V, et al. Landscape of the PARKIN-dependent ubiquitylome in response to mitochondrial depolarization. Nature. 2013;496:372–376.
   PubMed Web of Science ®Google Scholar
• Benard G, Neutzner A, Peng G, et al. IBRDC2, an IBR-type E3 ubiquitin ligase, is a regulatory factor for Bax and apoptosis activation. Embo J. 2010;29:1458–1471.
   PubMed Web of Science ®Google Scholar
• Burchell VS, Nelson DE, Sanchez-Martinez A, et al. The Parkinson’s disease-linked proteins Fbxo7 and Parkin interact to mediate mitophagy. Nat Neurosci. 2013;16:1257–1265.
   PubMed Web of Science ®Google Scholar
• Guan K, Zheng Z, Song T, et al. MAVS regulates apoptotic cell death by decreasing K48-linked ubiquitination of voltage-dependent anion channel 1. Mol Cell Biol. 2013;33:3137–3149.
   PubMed Web of Science ®Google Scholar
• Lavie J, De Belvalet H, Sonon S, et al. Ubiquitin-dependent degradation of mitochondrial proteins regulates energy metabolism. Cell Rep. 2018;23(10):2852–2863.
   PubMed Web of Science ®Google Scholar
• Yue M, Hinkle KM, Davies P, et al. Progressive dopaminergic alterations and mitochondrial abnormalities in LRRK2 G2019S knock-in mice. Neurobiol Dis. 2015;78:172–195.
   PubMed Web of Science ®Google Scholar
• Wiemerslage L, Lee D. Quantification of mitochondrial morphology in neurites of dopaminergic neurons using multiple parameters. J Neurosci Methods. 2016;262:56–65.
   PubMed Web of Science ®Google Scholar
• Perkins GA, Tjong J, Brown JM, et al. The micro-architecture of mitochondria at active zones: electron tomography reveals novel anchoring scaffolds and cristae structured for high-rate metabolism. J Neurosci. 2010;30:1015–1026.
   PubMed Web of Science ®Google Scholar
• Perkins GA, Renken CW, Frey TG, et al. Membrane architecture of mitochondria in neurons of the central nervous system. J Neurosci Res. 2001;66:857–865.
   PubMed Web of Science ®Google Scholar
• Gomes LC, Benedetto GD, Scorrano L. During autophagy mitochondria elongate, are spared from degradation and sustain cell viability. Nat Cell Biol. 2011;13:589–598.
   PubMed Web of Science ®Google Scholar
• Rambold AS, Kostelecky B, Elia N, et al. Tubular network formation protects mitochondria from autophagosomal degradation during nutrient starvation. Proc Natl Acad Sci USA. 2011;108:10190–10195.
   PubMed Web of Science ®Google Scholar
• Twig G, Elorza A, Molina AJ, et al. Fission and selective fusion govern mitochondrial segregation and elimination by autophagy. Embo J. 2008;27(2):433–446.
   PubMed Web of Science ®Google Scholar
• Mortiboys H, Thomas KJ, Koopman WJ, et al. Mitochondrial function and morphology are impaired in parkin-mutant fibroblasts. Ann Neurol. 2008;64(5):555–565.
   PubMed Web of Science ®Google Scholar
• Papkovskaia TD, Chau KY, Inesta-Vaquera F, et al. G2019S leucine-rich repeat kinase 2 causes uncoupling protein-mediated mitochondrial depolarization. Hum Mol Genet. 2012;21(19):4201–4213.
   PubMed Web of Science ®Google Scholar
• Mijaljica D, Prescott M, Devenish RJ. Different fates of mitochondria: alternative ways for degradation? Autophagy. 2007;3(1):4–9.
   PubMed Web of Science ®Google Scholar
• Kadowaki M, Karim MR. Cytosolic LC3 ratio as a quantitative index of macroautophagy. Methods Enzymol. 2009;452:199–213.
   PubMed Web of Science ®Google Scholar
• Toyofuku T, Okamoto Y, Ishikawa T, et al. LRRK2 regulates endoplasmic reticulum-mitochondrial tethering through the PERK-mediated ubiquitination pathway. Embo J. 2020;39(2):e100875.
   PubMed Web of Science ®Google Scholar
• Juárez-Flores DL, González-Casacuberta I, Ezquerra M, et al. Exhaustion of mitochondrial and autophagic reserve may contribute to the development of LRRK2 G2019S -Parkinson’s disease. J Transl Med. 2018;16(1):160.
   PubMedGoogle Scholar
• Dolman NJ, Chambers KM, Mandavilli B, et al. Tools and techniques to measure mitophagy using fluorescence microscopy. Autophagy. 2013;9(11):1653–1662.
   PubMed Web of Science ®Google Scholar
• Sun N, Malide D, Liu J, et al. A fluorescence-based imaging method to measure in vitro and in vivo mitophagy using mt-Keima. Nat Protoc. 2017;12(8):1576–1587.
   PubMed Web of Science ®Google Scholar
• Singh R, Cuervo AM. Autophagy in the cellular energetic balance. Cell Metab. 2011;13(5):495–504.
   PubMed Web of Science ®Google Scholar
• Palikaras K, Lionaki E, Tavernarakis N. Mechanisms of mitophagy in cellular homeostasis, physiology and pathology. Nat Cell Biol. 2018;20(9):1013–1022.
   PubMed Web of Science ®Google Scholar
• Narendra D, Tanaka A, Suen DF, et al. Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J Cell Biol. 2008;183(5):795–803.
   PubMed Web of Science ®Google Scholar
• Jagasia R, Grote P, Westermann B, et al. DRP-1-mediated mitochondrial fragmentation during EGL-1-induced cell death in C. elegans. Nature. 2005;433:754–760.
   PubMed Web of Science ®Google Scholar
• Wang X, Yan MH, Fujioka H, et al. LRRK2 regulates mitochondrial dynamics and function through direct interaction with DLP1. Hum Mol Genet. 2012;21(9):1931–1944.
   PubMed Web of Science ®Google Scholar
• Ho DH, Je AR, Lee H, et al. LRRK2 kinase activity induces mitochondrial fission in microglia via Drp1 and modulates neuroinflammation. Exp Neurobiol. 2018;27(3):171–180.
   PubMed Web of Science ®Google Scholar
• Biskup S, Moore DJ, Celsi F, et al. Localization of LRRK2 to membranous and vesicular structures in mammalian brain. Ann Neurol. 2006;60(5):557–569.
   PubMed Web of Science ®Google Scholar
• West AB, Moore DJ, Biskup S, et al. Parkinson’s disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity. Proc Natl Acad Sci USA. 2005;102(46):16842–16847.
   PubMed Web of Science ®Google Scholar
• Otera H, Ishihara N, Mihara K. New insights into the function and regulation of mitochondrial fission. Biochim Biophys Acta. 2013;1833(5):1256–1268.
   PubMed Web of Science ®Google Scholar
• Bonello F, Hassoun SM, Mouton-Liger F, et al. LRRK2 impairs PINK1/Parkin-dependent mitophagy via its kinase activity: pathologic insights into Parkinson’s disease. Hum Mol Genet. 2019;28(10):1645–1660.
   PubMed Web of Science ®Google Scholar
• Niu J, Yu M, Wang C, et al. Leucine-rich repeat kinase 2 disturbs mitochondrial dynamics via Dynamin-like protein. J Neurochem. 2012;122(3):650–658.
   PubMed Web of Science ®Google Scholar
• Smith GA, Jansson J, Rocha EM, et al. Fibroblast biomarkers of sporadic Parkinson’s disease and LRRK2 kinase inhibition. Mol Neurobiol. 2016;53(8):5161–5177.
   PubMed Web of Science ®Google Scholar
• Favaro G, Romanello V, Varanita T, et al. DRP1-mediated mitochondrial shape controls calcium homeostasis and muscle mass. Nat Commun. 2019;10(1):2576.
   PubMedGoogle Scholar
• Lemasters JJ. Variants of mitochondrial autophagy: types 1 and 2 mitophagy and micromitophagy (Type 3). Redox Biol. 2014;2:749–754.
   PubMed Web of Science ®Google Scholar
• Hailey DW, Rambold AS, Satpute-Krishnan P, et al. Mitochondria supply membranes for autophagosome biogenesis during starvation. Cell. 2010;141:656–667.
   PubMed Web of Science ®Google Scholar
• Hamasaki M, Furuta N, Matsuda A, et al. Autophagosomes form at ER-mitochondria contact sites. Nature. 2013;495:389–393.
   PubMed Web of Science ®Google Scholar
• Prieto J, León M, Ponsoda X, et al. Early ERK1/2 activation promotes DRP1-dependent mitochondrial fission necessary for cell reprogramming. Nat Commun. 2016;7:11124.
   PubMed Web of Science ®Google Scholar
• Martinez-Lopez N, Singh R. ATGs: scaffolds for MAPK/ERK signaling. Autophagy. 2014;10(3):535–537.
   PubMed Web of Science ®Google Scholar
• Bravo-San Pedro JM, Niso-Santano M, Gómez-Sánchez R, et al. The LRRK2 G2019S mutant exacerbates basal autophagy through activation of the MEK/ERK pathway. Cell Mol Life Sci. 2013;70(1):121–136.
   PubMed Web of Science ®Google Scholar
• Li X, Tan YC, Poulose S, et al. Leucine-rich repeat kinase 2 (LRRK2)/PARK8 possesses GTPase activity that is altered in familial Parkinson’s disease R1441C/G mutants. J Neurochem. 2007;103(1):238–247.
   PubMed Web of Science ®Google Scholar
• Nichols RJ, Dzamko N, Morrice NA, et al. 14-3-3 binding to LRRK2 is disrupted by multiple Parkinson’s disease-associated mutations and regulates cytoplasmic localization. Biochem J. 2010;430(3):393–404.
   PubMed Web of Science ®Google Scholar
• Kashatus JA, Nascimento A, Myers LJ, et al. Erk2 phosphorylation of Drp1 promotes mitochondrial fission and MAPK-driven tumor growth. Mol Cell. 2015;57(3):537–551.
   PubMed Web of Science ®Google Scholar
• Jahani-Asl A, Slack RS. The phosphorylation state of Drp1 determines cell fate. EMBO Rep. 2007;8(10):912–913.
   PubMed Web of Science ®Google Scholar
• Reddy PH, Reddy TP, Manczak M, et al. Dynamin-related protein 1 and mitochondrial fragmentation in neurodegenerative diseases. Brain Res Rev. 2011;67(1–2):103–118.
   PubMed Web of Science ®Google Scholar
• Yang X, Wang H, Ni HM, et al. Inhibition of Drp1 protects against senecionine-induced mitochondria-mediated apoptosis in primary hepatocytes and in mice. Redox Biol. 2017;12:264–273.
   PubMed Web of Science ®Google Scholar
• Szabadkai G, Simoni AM, Chami M, et al. Drp-1-dependent division of the mitochondrial network blocks intraorganellar Ca2+ waves and protects against Ca2+-mediated apoptosis. Mol Cell. 2004;16:59–68.
   PubMed Web of Science ®Google Scholar
• Knott AB, Perkins G, Schwarzenbacher R, et al. Mitochondrial fragmentation in neurodegeneration. Nat Rev Neurosci. 2008;9(7):505–518.
   PubMed Web of Science ®Google Scholar
• Wauters F, Cornelissen T, Imberechts D, et al. LRRK2 mutations impair depolarization-induced mitophagy through inhibition of mitochondrial accumulation of RAB10. Autophagy. 2020;16(2):203–222.
   PubMed Web of Science ®Google Scholar
• Karbowski M, Neutzner A. Neurodegeneration as a consequence of failed mitochondrial maintenance. Acta Neuropathol. 2012;123:157–171.
   PubMed Web of Science ®Google Scholar
• de Castro IP, Martins LM, Tufi R. Mitochondrial quality control and neurological disease: an emerging connection. Expert Rev Mol Med. 2010;12:e12.
   PubMed Web of Science ®Google Scholar
• Ho PWL, Ho JWM, Tse HM, et al. Uncoupling protein-4 (UCP4) increases ATP supply by interacting with mitochondrial Complex II in neuroblastoma cells. PLoS ONE. 2012;7(2):e32810.
   PubMed Web of Science ®Google Scholar